Introduction The overall goal of the Alzheimer's Disease Neuroimaging Initiative (ADNI) is to
validate biomarkers for Alzheimer's disease (AD) clinical trials. ADNI is a multisite …

Aging is characterized by changes in the structure and quality of sleep. When the alterations
in sleep become substantial, they can generate or accelerate cognitive decline, even in the …

Objectives Mild behavioral impairment (MBI) is a syndrome describing late-onset persistent
neuropsychiatric symptoms (NPS) in non-demented older adults. Few studies to date have …

Introduction Mild behavioral impairment (MBI) is characterized by the emergence of
neuropsychiatric symptoms in elderly persons. Here, we examine the associations between …

Background: Affective and emotional symptoms such as depression, anxiety, euphoria, and
irritability are common neuropsychiatric symptoms (NPS) in pre-dementia and cognitively …

Background Global brain health initiatives call for improving methods for the diagnosis of
Alzheimer's disease (AD) and frontotemporal dementia (FTD) in underrepresented …

Background: Machine learning (ML) is a promising technique for patient-specific prediction
of mild cognitive impairment (MCI) and dementia development. Neuropsychiatric symptoms …

Background: Neuropsychiatric symptoms (NPS) are non-cognitive, behavioral, or psychiatric
symptoms, common in mild cognitive impairment (MCI) and associated with a higher risk of …

Objective To compare different β-amyloid (Aβ), tau, and neurodegeneration (AT [N]) variants
within the Swedish BioFINDER studies. Methods A total of 490 participants were classified …

Objectives Agitation and aggression are common in dementia and pre‐dementia. The
dementia risk syndrome mild behavioral impairment (MBI) includes these symptoms in the …